Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 211-402-2 | CAS number: 643-79-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1989-06-23 to 1989-09-08
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 989
- Report date:
- 1989
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Version / remarks:
- adopted: Fenruary, 1987
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Phthalaldehyde
- EC Number:
- 211-402-2
- EC Name:
- Phthalaldehyde
- Cas Number:
- 643-79-8
- Molecular formula:
- C8H6O2
- IUPAC Name:
- phthalaldehyde
Constituent 1
- Specific details on test material used for the study:
- - Name used in the report: Phthaldialdehyd
- Appearance: Light yellow needles
- Batch No.: 1
- Purity: GC (area %) 99%
- Stablity of the test article: Stable
- Expiration date: 1989-12-31
- Stability of test article dilution: Unknown
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: BRL, Biological Research Laboratory Ltd., Wölferstrasse 4, CH-4414 Fullinsdorf, Switzerland
- Age at study initiation: Males: 9 weeks, Females: 11 weeks
- Weight at study initiation: Males: 197 - 236 g, Females: 176 - 194 g
- Fasting period before study: 12-18 h
- Housing: Groups of five animals were housed in Makrolon type-3 cages with standard softwood bedding
- Diet (e.g. ad libitum): Ad libitum, pelleted standard Kliba 343, Batches 46/89 and 48/89 rat maintenance diet
- Water (e.g. ad libitum): Ad libitum, tap water
- Acclimation period: One week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 3
- Humidity (%): 40-70
- Air changes (per hr): 10-15
- Photoperiod (hrs dark / hrs light): 12 / 12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- polyethylene glycol
- Details on oral exposure:
- MAXIMUM DOSE VOLUME APPLIED: 10 mL
DOSAGE PREPARATION (if unusual): The test article was placed into a glass beaker on a tared Mettler PE 360 balance, and the vehicle, (polyethylene glycol PEG 400) was added. A weight by volume dilution was prepared using a homogenizer.
- Doses:
- 50, 150, 300 and 2000 mg /kg
- No. of animals per sex per dose:
- 5 males and 5 females per dose group, 4 dose groups
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 15 days
- Frequency of observations: Four times during test day 1, and daily during days 2 - 15 (mortality, viability and clinical signs).
- Frequency of weighing: Test days 1 (pre-administration), 8 and 15.
- Necropsy of survivors performed: yes
- Other examinations performed: no - Statistics:
- The LOGIT-Model (COX, Analysis of Binary Data, London 1977) was applied to estimate the toxicity value. Additionally, the 90, 95 and 99 % confidence limits for the toxicity for each sex and the slope of the dose response line were estimated.
Results and discussion
- Preliminary study:
- n.a.
Effect levelsopen allclose all
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 178.46 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 50.02 - <= 434.36
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 339.67 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 152.35 - <= 1 000.76
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 238.12 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 141.27 - <= 401.39
- Mortality:
- Test item related mortality was observed at at 300 and 2000 mg/kg in males and in 150, 300 and 2000 mg/kg in females. For individual results see Table 1 in box "Any other information on results incl. tables".
- Clinical signs:
- No clinical signs were observed for male and female rats at 50 mg/kg. At 150 mg/kg, ruffled fur was observed in male and female rats and sedated, hunched posture was observed in female rats. At 300 mg/kg, sedated, dyspnea hunched posture and ruffled fur was observed in male and female rats, ventral recumbency was observed in male rats and lateral recumbency, uncoordinated movements were observed in female rats. At 2000 mg/kg, sedated, ventral recumbency, hunched posture and dyspnea was observed in male and female rats, ruffled fur was observed in male rats and lateral recumbency was observed in female rats.
- Body weight:
- The body weights of the surviving males and females of group 1 (50 mg/kg) and those of the males of group 2 (150 mg/kg) were not affected by the test article treatment. The surviving females of group 2 (150 mg/kg) showed the same reactions as the males, whereas one female showed a body weight reduction after 8 days. It had recovered at termination of observation (day 15).
One surviving male of group 3 (300 mg/kg) showed no effect in body weight, whereas the second survivor showed a reduction after 8 days. It was recovered at termination of observation. - Gross pathology:
- No pathological findings were observed at 50, 150 and 2000 mg/kg dose level. At 300 mg/kg, discoloration and paleness was observed in the lungs and black-brown contents were observed in the stomach of dead rats. No findings were observed in the sacrificed rats.
- Other findings:
- n.a.
Any other information on results incl. tables
Table 1:Number of Decendents after Treatment
Test day | 1 | 1 | 1 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | |
Hours after treatment | 1 | 2 | 3 | 5 | |||||||||||||||
Males | Group 1 (50 mg/kg) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Group 2 (150 mg/kg) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
Group 3 (300 mg/kg) | - | - | - | 2 | 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | |
Group 4 (2000 mg/kg) | - | 2 | 2 | 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
Females | Group 1 (50 mg/kg) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Group 2 (150 mg/kg) | - | - | - | - | 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | |
Group 3 (300 mg/kg) | - | - | - | 4 | 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | |
Group 4 (2000 mg/kg) | 3 | 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Applicant's summary and conclusion
- Interpretation of results:
- Category 3 based on GHS criteria
- Conclusions:
- Under the conditions of this study, the oral LD50 of the test material was 178.46 mg/kg for females, 339.67 mg/kg for males and 238.12 mg/kg for both male and female rats. Thus, the test substance is classified under "Category 3" according to CLP criteria
- Executive summary:
In an acute oral toxicity study conducted according to OECD guideline 401, young adult Wistar rats (5/sex/dose) were given a single 10 mL, oral dose of the test substance, ortho-phthalaldehyde (purity: 99%) in polyethylene glycol at dose levels of 50,150, 300 and 2000 mg/kg bw and were observed for 15 days. Test item related mortality, body weight changes and clinical signs were observed in male and female rats above the 150 mg/kg dose level. Thus, the acute oral LD50 of the test material was 178.46 mg/kg for females, 339.67 mg/kg for males and 238.12 mg/kg for both male and female rats.
Based on these results, the test substance is classified under "Category 3" according to CLP criteria.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.